Althaea rosea Cavanil and Plantago major L. suppress neoplastic cell transformation through the inhibition of epidermal growth factor receptor kinase

Molecular Medicine Reports

Volumn 6, Issue 4, 2012, Pages 843-847

  Choi, Eun Sun ^a   Cho, Sung Dae ^a   Shin, Ji Ae ^a   Kwon, Ki Han ^b   Cho, Nam Pyo ^a   Shim, Jung Hyun ^c  

^a Chonbuk National University   (South Korea)

^b Kwangju University   (South Korea)

^c Soonchunhyang University   (South Korea)

Author keywords

Althaea rosea Cavanil; Epidermal growth factor receptor; Plantago major L.; Skin carcinogenesis

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; METHANOL; METHANOL ALTHAEA ROSEA CAVANIL EXTRACT; METHANOL PLANTAGO MAJOR L EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ALTHAEA ROSEA CAVANIL; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL TRANSFORMATION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME INHIBITION; EPIDERMIS CELL; MEDICINAL PLANT; MOUSE; NONHUMAN; PLANTAGO MAJOR; WESTERN BLOTTING;

ALTHAEA; ANIMALS; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; EPIDERMAL GROWTH FACTOR; FIBROBLASTS; METHANOL; MICE; PHOSPHORYLATION; PLANT EXTRACTS; PLANTAGO; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84865167375     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.977     Document Type: Article

References (40)

1. Wang H, Zhou M, Shi B, et al: Identification of an exon 4-deletion variant of epidermal growth factor receptor with increased metastasis-promoting capacity. Neoplasia 13: 461-471, 2011.
2. Xue C, Wyckoff J, Liang F, et al: Epidermal growth factor receptor overexpression results in increased tumor cell motility in vivo coordinately with enhanced intravasation and metastasis. Cancer Res 66: 192-197, 2006. (Pubitemid 43166025)
3. Pandiella A, Lehvaslaiho H, Magni M, Alitalo K and Meldolesi J: Activation of an EGFR/neu chimeric receptor: early intracellular signals and cell proliferation responses. Oncogene 4: 1299-1305, 1989. (Pubitemid 19273585)
4. Liang K, Ang KK, Milas L, Hunter N and Fan Z: The epidermal growth factor receptor mediates radioresistance. Int J Radiat Oncol Biol Phys 57: 246-254, 2003. (Pubitemid 36959763)
5. Ho R, Minturn JE, Hishiki T, et al: Proliferation of human neuroblastomas mediated by the epidermal growth factor receptor. Cancer Res 65: 9868-9875, 2005. (Pubitemid 41541466)
6. Modjtahedi H and Essapen S: Epidermal growth factor receptor inhibitors in cancer treatment: advances, challenges and opportunities. Anticancer Drugs 20: 851-855, 2009.
7. Engelman JA and Cantley LC: A sweet new role for EGFR in cancer. Cancer Cell 13: 375-376, 2008. (Pubitemid 351609447)
8. Chaffanet M, Chauvin C, Laine M, et al: EGF receptor amplification and expression in human brain tumours. Eur J Cancer 28: 11-17, 1992.
9. Nishikawa R, Ji XD, Harmon RC, et al: A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity. Proc Natl Acad Sci USA 91: 7727-7731, 1994. (Pubitemid 24238258)
10. Tang P, Steck PA and Yung WK: The autocrine loop of TGF-alpha/EGFR and brain tumors. J Neurooncol 35: 303-314, 1997. (Pubitemid 27511133)
11. Hwang MK, Bode AM, Byun S, et al: Cocarcinogenic effect of capsaicin involves activation of EGFR signaling but not TRPV1. Cancer Res 70: 6859-6869, 2010.
12. Newman DJ, Cragg GM and Snader KM: Natural products as sources of new drugs over the period 1981-2002. J Nat Prod 66: 1022-1037, 2003. (Pubitemid 36909859)
13. Graham JG, Quinn ML, Fabricant DS and Farnsworth NR: Plants used against cancer - an extension of the work of Jonathan Hartwell. J Ethnopharmacol 73: 347-377, 2000.
14. Samuelsen AB: The traditional uses, chemical constituents and biological activities of Plantago major L. A review. J Ethnopharmacol 71: 1-21, 2000.
15. Galvez M, Martin-Cordero C, Lopez-Lazaro M, Cortes F and Ayuso MJ: Cytotoxic effect of Plantago spp. on cancer cell lines. J Ethnopharmacol 88: 125-130, 2003. (Pubitemid 37083436)
16. Papiez MA: The influence of hollyhock extract administration on testicular function in rats. J Mol Histol 35: 733-740, 2004. (Pubitemid 41404618)
17. Kang NJ, Lee KW, Rogozin EA, et al: Equol, a metabolite of the soybean isoflavone daidzein, inhibits neoplastic cell transformation by targeting the MEK/ERK/p90RSK/activator protein-1 pathway. J Biol Chem 282: 32856-32866, 2007. (Pubitemid 350159319)
18. Ehmann LM, Heinemann V and Wollenberg A: New tyrosine kinase and EGFR inhibitors in cancer therapy : Cardiac and skin toxicity as relevant side effects. Part B: skin. Internist (Berl) 52: 1359-1364, 2011 (In German).
19. Cheung CW, Gibbons N, Johnson DW and Nicol DL: Silibinin - a promising new treatment for cancer. Anticancer Agents Med Chem 10: 186-195, 2010.
20. Fahey JW, Haristoy X, Dolan PM, et al: Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors. Proc Natl Acad Sci USA 99: 7610-7615, 2002. (Pubitemid 34568739)
21. Yanaka A, Fahey JW, Fukumoto A, et al: Dietary sulforaphane-rich broccoli sprouts reduce colonization and attenuate gastritis in Helicobacter pylori-infected mice and humans. Cancer Prev Res (Phila) 2: 353-360, 2009.
22. Butler MS: The role of natural product chemistry in drug discovery. J Nat Prod 67: 2141-2153, 2004.
23. Koehn FE and Carter GT: The evolving role of natural products in drug discovery. Nat Rev Drug Discov 4: 206-220, 2005. (Pubitemid 40372555)
24. Shokrzadeh M, Azadbakht M, Ahangar N, Hashemi A and Saeedi Saravi SS: Cytotoxicity of hydro-alcoholic extracts of Cucurbitapepo and Solanum nigrum on HepG2 and CT26 cancer cell lines. Pharmacogn Mag 6: 176-179, 2010.
25. Etkin NL: A Hausa herbal pharmacopoeia: biomedical evaluation of commonly used plant medicines. J Ethnopharmacol 4: 75-98, 1981.
26. Misumi N, Hiraike M, Nawata F, et al: [Protective effects of d-chlorpheniramine maleate pre-treatment against acute side effects of Irinotecan(CPT- 11)]. Gan To Kagaku Ryoho 38: 1149-1153, 2011 (In Japanese).
27. Sun X, Zhang J, Gupta R, Macgibbon AK, Kuhn-Sherlock B and Krissansen GW: Dairy milk fat augments paclitaxel therapy to suppress tumour metastasis in mice, and protects against the side-effects of chemotherapy. Clin Exp Metastasis 28: 675-688 2011.
28. Wang DF, Shang JY and Yu QH: Analgesic and anti-inflammatory effects of the flower of Althaea rosea (L.) Cav. Zhongguo Zhong Yao Za Zhi 14: 46-48, 64, 1989 (In Chinese).
29. Furuse J: Growth factors as therapeutic targets in HCC. Crit Rev Oncol Hematol 67: 8-15, 2008.
30. Khalil MY, Grandis JR and Shin DM: Targeting epidermal growth factor receptor: novel therapeutics in the management of cancer. Expert Rev Anticancer Ther 3: 367-380, 2003. (Pubitemid 36748047)
31. Mimeault M, Pommery N and Henichart JP: New advances on prostate carcinogenesis and therapies: involvement of EGF-EGFR transduction system. Growth Factors 21: 1-14, 2003. (Pubitemid 36790449)
32. Amstad PA, Liu H, Ichimiya M, Berezesky IK and Trump BF: Manganese superoxide dismutase expression inhibits soft agar growth in JB6 clone41 mouse epidermal cells. Carcinogenesis 18: 479-484, 1997. (Pubitemid 28132483)
33. Kang NJ, Lee KW, Kwon JY, et al: Delphinidin attenuates neoplastic transformation in JB6 Cl41 mouse epidermal cells by blocking Raf/mitogen-activated protein kinase kinase/extracellular signal-regulated kinase signaling. Cancer Prev Res (Phila) 1: 522-531, 2008.
34. Dong Z and Bode AM: Proceedings - targeting carcinogenesis: transduction, transcription, translation. Mol Carcinog 45: 353-354, 2006. (Pubitemid 43865840)
35. Nguyen-Ba G and Vasseur P: Epigenetic events during the process of cell transformation induced by carcinogens (Review). Oncol Rep 6: 925-932, 1999.
36. Lee KW, Kang NJ, Rogozin EA, et al: Myricetin is a novel natural inhibitor of neoplastic cell transformation and MEK1. Carcinogenesis 28: 1918-1927, 2007. (Pubitemid 47500604)
37. Ciardiello F and Tortora G: EGFR antagonists in cancer treatment. N Engl J Med 358: 1160-1174, 2008.
38. Gschwind A, Zwick E, Prenzel N, Leserer M and Ullrich A: Cell communication networks: epidermal growth factor receptor transactivation as the paradigm for interreceptor signal transmission. Oncogene 20: 1594-1600, 2001. (Pubitemid 32336847)
39. Fichera A, Little N, Jagadeeswaran S, et al: Epidermal growth factor receptor signaling is required for microadenoma formation in the mouse azoxymethane model of colonic carcinogenesis. Cancer Res 67: 827-835, 2007. (Pubitemid 46192224)
40. Wakeling AE, Guy SP, Woodburn JR, et al: ZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy. Cancer Res 62: 5749-5754, 2002. (Pubitemid 35204731)